1. Tian, E, Stevens, Sharon R, Guan, Yu, Ten Hagen, Kelly G, Tabak, Lawrence A. 2015. Galnt1 is required for normal heart valve development and cardiac function. In PloS one, 10, e0115861. doi:10.1371/journal.pone.0115861. https://pubmed.ncbi.nlm.nih.gov/25615642/
2. Oshi, Masanori, Ziazadeh, Danya, Wu, Rongrong, Endo, Itaru, Takabe, Kazuaki. 2023. GALNT1 Expression Is Associated with Angiogenesis and Is a Prognostic Biomarker for Breast Cancer in Adolescents and Young Adults (AYA). In Cancers, 15, . doi:10.3390/cancers15133489. https://pubmed.ncbi.nlm.nih.gov/37444599/
3. Sun, Chen-Min, Zhang, Wen-Yi, Wang, Shu-Yan, Pei, Dong-Liang, Zhang, Guang-Ming. . microRNA let-7i-5p aggravates kidney fibrosis via targeting GALNT1. In General physiology and biophysics, 40, 147-154. doi:10.4149/gpb_20210031. https://pubmed.ncbi.nlm.nih.gov/33881001/
4. Huang, Miao-Juei, Hu, Rey-Heng, Chou, Chih-Hsing, Wu, Yao-Ming, Huang, Min-Chuan. . Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling. In Oncotarget, 6, 5650-65. doi:. https://pubmed.ncbi.nlm.nih.gov/25730904/
5. Phelan, Catherine M, Tsai, Ya-Yu, Goode, Ellen L, Berchuck, Andrew, Sellers, Thomas A. . Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 600-4. doi:10.1158/1055-9965.EPI-09-0861. https://pubmed.ncbi.nlm.nih.gov/20142253/
6. Osman, Tagwa E, Guo, Yanru, Li, Shijun. 2025. Exploring the combined roles of GALNT1 and GALNT2 in hepatocellular carcinoma malignancy and EGFR modulation. In Discover oncology, 16, 337. doi:10.1007/s12672-025-02069-2. https://pubmed.ncbi.nlm.nih.gov/40095226/
智鼠故事 
